Published in Br J Haematol on August 01, 2000
A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer (2007) 1.25
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer (2006) 0.96
Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer (2004) 0.95
Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer (2011) 0.93
Oral manifestations in transplant patients. Dent Res J (Isfahan) (2015) 0.91
Oral mucositis induced by anticancer treatments: physiopathology and treatments. Ther Clin Risk Manag (2006) 0.89
Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators Inflamm (2014) 0.84
Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Med Oral Patol Oral Cir Bucal (2012) 0.83
Oral Mucositis Induced By Anticancer Therapies. Curr Oral Health Rep (2015) 0.83
Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy. BMC Oral Health (2006) 0.82
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant. Support Care Cancer (2007) 0.82
Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation. Support Care Cancer (2012) 0.79
Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy. Support Care Cancer (2011) 0.78
Role of antioxidants in buccal mucosa cells and plasma on the incidence and severity of oral mucositis after allogeneic haematopoietic cell transplantation. Support Care Cancer (2011) 0.78
Oral health as a predictive factor for oral mucositis. Clinics (Sao Paulo) (2013) 0.77
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation. Support Care Cancer (2009) 0.77
Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa. Bone Marrow Transplant (2014) 0.77
Challenges and outcomes of a randomized study of early nutrition support during autologous stem-cell transplantation. Curr Oncol (2014) 0.76
The nature of small intestinal mucositis: a video-capsule endoscopy study. Support Care Cancer (2008) 0.76
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT. Bone Marrow Transplant (2016) 0.75
Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management. Clin Chest Med (2017) 0.75
CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation. Support Care Cancer (2015) 0.75
Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy. Support Care Cancer (2009) 0.75
A C. elegans mutant that lives twice as long as wild type. Nature (1993) 20.42
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer (1983) 4.33
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res (1999) 3.40
IMMUNIZATION WITH DIPHTHERIA TOXOID (ANATOXINE RAMON). Am J Public Health (N Y) (1927) 3.22
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer (2007) 2.98
Childhood leukaemia in North West England 1954-1977: epidemiology, incidence and survival. Br J Cancer (1981) 2.97
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med (1993) 2.96
To clot or not to clot? That is the question in central venous catheters. Clin Radiol (2004) 2.85
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell (2000) 2.76
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet (2000) 2.50
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data. Br J Cancer (1980) 2.40
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
Extramedullary plasmacytoma of the head and neck region: clinicopathological correlation in 25 cases. Br J Cancer (1997) 2.18
Concomitant methotrexate and radiotherapy in advanced head and neck cancer: 15-year follow-up of a randomized clinical trial. Clin Oncol (R Coll Radiol) (2001) 2.16
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J Biol Chem (2000) 1.98
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr Biol (2001) 1.89
Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol (2000) 1.89
Broken rotational symmetry in the pseudogap phase of a high-T(c) superconductor. Nature (2010) 1.82
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer (2009) 1.78
Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold. BMJ (1999) 1.77
Heparan sulfate proteoglycans and cancer. Br J Cancer (2001) 1.75
Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation. Blood (2001) 1.75
Selection of axial growth sites in yeast requires Axl2p, a novel plasma membrane glycoprotein. Genes Dev (1996) 1.75
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer (2008) 1.74
Nationwide survey of human parasite in China. Southeast Asian J Trop Med Public Health (1994) 1.72
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br J Cancer (1984) 1.70
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol (2003) 1.61
Intra-tumoural microvessel density in human solid tumours. Br J Cancer (2002) 1.60
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood (2000) 1.58
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet (1999) 1.57
Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood (1993) 1.56
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol (2006) 1.55
Estimation of renal function -- what is appropriate in cancer patients? Clin Oncol (R Coll Radiol) (2008) 1.55
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. Digestion (1990) 1.54
Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol) (2013) 1.54
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol (1998) 1.53
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol (1999) 1.51
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. Br J Radiol (2005) 1.50
HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet (1993) 1.50
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol (1991) 1.48
Biodegradable rapamycin-eluting nano-fiber membrane-covered metal stent placement to reduce fibroblast proliferation in experimental stricture in a canine model. Endoscopy (2013) 1.48
Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol (1986) 1.47
The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. Br J Cancer (1998) 1.44
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
The value of hyoscine butylbromide in pelvic MRI. Clin Radiol (2007) 1.43
Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy. Clin Radiol (2003) 1.42
Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol (2012) 1.42
Carcinosarcoma of the ovary. Br J Cancer (2003) 1.41
Acute lymphoid leukaemia of childhood in North-West England. Lancet (1979) 1.41
X-ray diffraction observations of a charge-density-wave order in superconducting ortho-II YBa2Cu3O6.54 single crystals in zero magnetic field. Phys Rev Lett (2013) 1.41
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer (2011) 1.40
Combined innominate artery reconstruction and coronary artery bypass grafting. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 1.39
The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice. Blood (1997) 1.39
Preoperative radiotherapy for operable rectal cancer--is a lower dose to a reduced volume acceptable? Clin Oncol (R Coll Radiol) (2006) 1.39
Tumour lysis syndrome, case report and review of the literature. Ann Oncol (1996) 1.39
Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol (2006) 1.39
The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) (1993) 1.39
Hypospadias repair: collaboration between urologist and plastic surgeon. Ann Plast Surg (2000) 1.38
The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A (1989) 1.38
Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions (1985) 1.37
Studies on cellular autophagocytosis. Relationship between heterophagy and autophagy in HeLa cells. Lab Invest (1971) 1.35
Inhibition by glucocorticoids of prostaglandin release from adipose tissue in vitro. Br J Pharmacol (1977) 1.35
Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer (1992) 1.34
Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Ann Behav Med (1999) 1.33
Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surfaces using a hydrogen peroxide gas generator. J Appl Microbiol (2005) 1.33
Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation. J Biol Chem (1997) 1.32
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Functional vision and corneal changes after laser in situ keratomileusis determined by contrast sensitivity, glare testing, and corneal topography. J Cataract Refract Surg (1999) 1.30
Emergent quantum confinement at topological insulator surfaces. Nat Commun (2012) 1.29
Non-secretory multiple myeloma: a report of 13 cases with a review of the literature. Hematol Oncol (1987) 1.29
Cloning and characterization of a human beta,beta-carotene-15,15'-dioxygenase that is highly expressed in the retinal pigment epithelium. Genomics (2001) 1.28
Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant (2003) 1.28
Phospholipase A2: function and pharmacological regulation. Biochem Pharmacol (1987) 1.27
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer (1985) 1.26